NetworkNewsBreaks Archive - Page 2083 of 2138

TuesdayFeb 21, 2017 11:48 am

NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Initiates Collaborative Research Program with Viatar for Early Pancreatic Cancer Detection

Interpace Diagnostics (NASDAQ: IDXG) is trading higher on news of its collaborative research program with Viatar CTC Solutions Inc. The partnership will combine Viatar's circulating tumor cell collection technology with Interpace's commercialized PancraGEN™ assay used to help assess unknown pancreatic cancer biopsies in patients with pancreatic cysts. Studies are being designed to identify patients most likely to develop pancreatic cancer in the near future as well as to detect pancreatic cancer at its earliest stage of development. These studies may lead to the enactment of early diagnostic testing and assessment for patients with pancreatic diseases, as well as for those…

TuesdayFeb 21, 2017 10:06 am

NetworkNewsBreaks – EyeGate (NASDAQ: EYEG) Inks Licensing Deal with Valeant Pharmaceuticals (NYSE: VRX); Shares Higher

EyeGate Pharmaceuticals (NASDAQ: EYEG) is trading 39% higher this morning on news of its exclusive, worldwide licensing agreement with Valeant Pharmaceuticals (NYSE: VRX). Shares of Valeant are up 4%. The company has allowed a subsidiary of Valeant commercial and manufacturing rights to the EyeGate® II Delivery System and EGP-437 combination product candidate for the treatment of post-operative pain and inflammation in ocular surgery patients. Per the agreement, EyeGate received an upfront cash payment and will receive royalties on Valeant's net sales of the product. Additionally, the company may also receive development-based and sale-based milestone payments. This partnership follows a 2015…

TuesdayFeb 21, 2017 10:02 am

NetworkNewsBreaks – MTBC’s (NASDAQ: MTBC) talkEHR™ Platform Receives 2015 Edition ONC Health IT Certification

Health care information technology company Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) this morning announced that its voice-enabled EHR platform, talkEHR™, received 2015 Edition Health IT certification as a Health IT Module from ICSA Labs on February 3, 2017. Certification criteria related to the ONC Health IT 2015 Edition Certification Program aim to enhance privacy and security capabilities, improve patient safety and interoperability and improve upon the reliability and transparency of certified Health IT. “talkEHR 'breaks the mold' in the EHR industry by melding the advanced functionality required under Meaningful Use Stage 3 with one of the most user-friendly interfaces…

TuesdayFeb 21, 2017 9:37 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Subsidiary Set to Unveil New Partnership Program at GSMA Mobile World Congress 2017

Global payment technology provider Net Element, Inc. (NASDAQ: NETE), through subsidiary Digital Provider, this morning announced plans to introduce a new partnership aimed at content providers, mobile network operators and mobile application developers during the GMSA Mobile World Congress 2017, which is set to take place in Barcelona, Spain, from February 27 to March 2, 2017. As the world’s largest gathering for the mobile industry, the Mobile World Congress will allow Digital Provider to meet face-to-face with existing partners while providing an opportunity to open dialogues with new mobile network operators (MNOs) and potential clients. The company’s current network includes…

FridayFeb 17, 2017 1:09 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 17, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: STBR 19.30% – News: Closes private placement of $327,500 MVEN 17.00% – News: Immigrant activist Jose Antonio Vargas joins TheMaven Network CXDC 14.37% – News: Receives preliminary non-binding "going private" proposal OWCP 10.54% – News: Presenting at the Wall Street Conference March 1, 2017 DTRM 8.41% – News: Maintains position as a visionary in the latest Magic Quadrant for Strategic Sourcing Application Suites RWLK 6.52% – News: Posts Q4, full-year 2016 results MSRT 5.92%…

FridayFeb 17, 2017 1:09 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Spots Revenue-generating Opportunities in Shingles Recycling

National Waste Management (OTC: NWMH) continues to find new forms of revenue, and through market observation expects to see a significant increase in shingles recycling. “National Waste projects exponential growth in the coming years for the recycling of shingles. The company plans on adding a portable picking station at its landfill in order to increase its concrete recycling program by 25%. Overall, the portable picking station is expected to boost National Waste’s recyclables rate, the company said. National Waste also sells ground wood product to bio-mass energy plants. Additionally, the company markets a line of its own mulch and garden…

FridayFeb 17, 2017 12:29 pm

NetworkNewsBreaks – MTBC (NASDAQ: MTBC) Partners with Pikeville Medical Center for East Kentucky Heart Ball

MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, has partnered with Pikeville Medical Center as a key event sponsor for the hospital's East Kentucky Heart Ball. The fundraiser benefits Pikeville's Heart and Vascular Institute. MediGain Practice Management, an MTBC company, has provided end-to-end revenue cycle management services to Pikeville since October 2016. Every year, the fundraiser brings together a variety of guests including medical, business, and political leaders. Over 400 people attended the fundraiser to show their support this year. "The fulfillment of Pikeville's mission ensures that area residents can…

FridayFeb 17, 2017 10:44 am

NetworkNewsBreaks – ArQule, Inc. (NASDAQ: ARQL) Shares Sink on Disappointing Liver Cancer Trial

Shares of ArQule (NASDAQ: ARQL) dropped more than 20% this morning on news that the company, along with Daiichi Sankyo Cancer Enterprise, announced that the METIV-HCC phase 3 study of tivantinib in hepatocellular carcinoma (HCC) did not meet its primary endpoint of improving overall survival. A total of 340 patients with MET-overexpressing HCC analyzed by a validated immunohistochemical assay were randomized in the intent-to-treat population for efficacy analysis. Full results from the trial will be presented at an upcoming scientific forum. “HCC is a disease with high unmet need, especially in the second-line setting, so these results are disappointing for…

FridayFeb 17, 2017 10:42 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) Takes Aim at Growing Digital Ad Markets

As a progressive Internet advertising firm, Social Reality (NASDAQ: SRAX) has its sights on the worldwide real-time bidding (RTB) and social media advertising markets. “Designed to position itself in these multi-billion dollar markets, Social Reality, Inc. is a multi-platform company specializing in digital advertising. Its Social Reality Ad Exchange is a real-time buying and selling management platform designed for launching social media and other campaigns. SRAX Social offers targeted ad purchasing in the digital marketplace, while SRAX.md is designed to help clients reach health care professionals.” To view the full article, visit: http://nnw.fm/CkN0u About Social Reality Social Reality, Inc. is…

FridayFeb 17, 2017 9:57 am

NetworkNewsBreaks – Heat Biologics, Inc. (NASDAQ: HTBX) Shares Climb following Presentation of Positive Immune Data on HS-410 Phase 2 Bladder Cancer Trial

Shares of Heat Biologics (NASDAQ: HTBX) are up 8% on news that the company presented immunological data from its phase 2 trial evaluating HS-410 either alone or in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) at the 2017 Genitourinary Cancers Symposium. Researchers reported that HS-410, in combination with BCG, is generally well-tolerated, and that HS-410 activates CD8+ T cells and that these immune responders appear to have a lower recurrence rate than non-immune responders. Overall, this data strengthens support for the vaccine mechanism of action and clinical proof-of-concept of immune activation. “These data continue to support…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks